HK1066164A1 - Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles - Google Patents

Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles

Info

Publication number
HK1066164A1
HK1066164A1 HK04109100A HK04109100A HK1066164A1 HK 1066164 A1 HK1066164 A1 HK 1066164A1 HK 04109100 A HK04109100 A HK 04109100A HK 04109100 A HK04109100 A HK 04109100A HK 1066164 A1 HK1066164 A1 HK 1066164A1
Authority
HK
Hong Kong
Prior art keywords
extract
ginkgo biloba
biloba leaves
ethyl acetate
liquid
Prior art date
Application number
HK04109100A
Other languages
English (en)
Inventor
Beng-Poon Teng
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of HK1066164A1 publication Critical patent/HK1066164A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK04109100A 2001-04-10 2004-11-18 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles HK1066164A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0104942A FR2823116B1 (fr) 2001-04-10 2001-04-10 Procede de preparation d'une extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs
PCT/FR2002/001219 WO2002083158A1 (fr) 2001-04-10 2002-04-09 Procede de preparation d'un extrait de feuilles de ginkgo biloba hautement enrichi en principes actifs

Publications (1)

Publication Number Publication Date
HK1066164A1 true HK1066164A1 (en) 2005-03-18

Family

ID=8862215

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04109100A HK1066164A1 (en) 2001-04-10 2004-11-18 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles

Country Status (20)

Country Link
US (1) US7048954B2 (xx)
EP (1) EP1379262B1 (xx)
JP (1) JP4416404B2 (xx)
KR (1) KR100876233B1 (xx)
CN (1) CN1245167C (xx)
AT (1) ATE278411T1 (xx)
AU (1) AU2002307981B2 (xx)
CA (1) CA2443302C (xx)
CZ (1) CZ299652B6 (xx)
DE (1) DE60201525T8 (xx)
DK (1) DK1379262T3 (xx)
ES (1) ES2230512T3 (xx)
FR (1) FR2823116B1 (xx)
HK (1) HK1066164A1 (xx)
HU (1) HUP0303797A3 (xx)
NZ (1) NZ528571A (xx)
PL (1) PL204867B1 (xx)
PT (1) PT1379262E (xx)
RU (1) RU2297235C2 (xx)
WO (1) WO2002083158A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040031772A (ko) 2001-07-11 2004-04-13 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 은행의 잎 및 약제학적 분말로부터 테르펜트리락톤(징코라이드, 빌로바라이드)을 분리하는 방법
WO2003082185A2 (en) 2002-03-29 2003-10-09 The Trustees Of Columbia University In The City Of New York Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof
JP2004307396A (ja) 2003-04-07 2004-11-04 Kao Corp デオドラント剤
US7429670B2 (en) 2003-08-27 2008-09-30 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide C
WO2005046829A2 (en) 2003-11-12 2005-05-26 The Trustees Of Columbia University In The City Of New York Separation of ginkgolides and bilobalide from g. biloba
ES2287403T3 (es) * 2003-12-04 2007-12-16 Cognis Ip Management Gmbh Metodo para la produccion de extractos de ginkgo biloba.
WO2006004386A1 (es) * 2004-07-02 2006-01-12 Rojas Castaneda Patricia Uso de un extracto del ginkgo biloba para preparar una medicina para tratar la enfermedad de parkinson
CN1891242B (zh) * 2005-07-06 2012-01-04 徐州技源天然保健品有限公司 一种从银杏叶提取物中脱除多环芳烃的生产工艺
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
CZ299802B6 (cs) * 2006-10-12 2008-11-26 Kalvoda@Jaroslav Príprava zálivky obsahující extrakt z náprstníku cerveného, extrakt z jinanu dvoulalocného a dusicnan draselný, a její vliv na rostliny
HUE041715T2 (hu) * 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
FR2926994B1 (fr) * 2008-02-06 2010-08-27 Sod Conseils Rech Applic Nouveau procede pour la preparation d'extraits de ginkgo biloba
WO2011012141A1 (en) * 2009-07-28 2011-02-03 Velleja Research S.R.L. Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1044659C (zh) * 1987-06-30 1999-08-18 吴羽化学工业株式会社 含有唑类衍生物的农业和园艺用的农药组合物
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
JPH02193907A (ja) * 1989-01-19 1990-07-31 Daicel Chem Ind Ltd イチョウエキスの製法
KR940002796B1 (ko) * 1989-06-16 1994-04-02 주식회사 선경인더스트리 은행잎에서 징코라이드를 분리 및 정제하는 방법
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
GB9107425D0 (en) * 1991-04-09 1991-05-22 Scras Preparation of ginkgolide b
GB9408044D0 (en) * 1994-04-22 1994-06-15 Sod Conseils Rech Applic Conversion of ginkgolide c to ginkgolide b
DE19756848C2 (de) * 1997-12-19 2003-01-16 Schwabe Willmar Gmbh & Co Extrakte aus Blättern von Ginkgo biloba mit vermindertem Gehalt an 4'-O-Methylpyridoxin und Biflavonen
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
CN1124275C (zh) * 2000-06-02 2003-10-15 天津大学 由银杏叶或银杏叶浸膏制备药物银杏内酯a、b的方法
DK1163908T3 (da) * 2000-06-16 2004-07-12 Linnea Sa Vandoplöseligt kompleks af et ekstrakt af Ginkgo biloba, fremgangsmåde til fremstilling heraf og sammensætning, der indeholder komplekset
KR20040031772A (ko) * 2001-07-11 2004-04-13 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 은행의 잎 및 약제학적 분말로부터 테르펜트리락톤(징코라이드, 빌로바라이드)을 분리하는 방법

Also Published As

Publication number Publication date
FR2823116B1 (fr) 2004-11-19
JP4416404B2 (ja) 2010-02-17
DE60201525T8 (de) 2006-08-24
US7048954B2 (en) 2006-05-23
JP2004538263A (ja) 2004-12-24
EP1379262B1 (fr) 2004-10-06
PT1379262E (pt) 2005-02-28
RU2297235C2 (ru) 2007-04-20
CA2443302C (fr) 2012-09-18
HUP0303797A2 (hu) 2004-03-29
CN1501806A (zh) 2004-06-02
CZ20033055A3 (cs) 2004-06-16
ES2230512T3 (es) 2005-05-01
CZ299652B6 (cs) 2008-10-01
PL366938A1 (en) 2005-02-07
HUP0303797A3 (en) 2005-05-30
NZ528571A (en) 2005-06-24
EP1379262A1 (fr) 2004-01-14
RU2003132470A (ru) 2005-03-10
AU2002307981B2 (en) 2006-11-23
CA2443302A1 (fr) 2002-10-24
DE60201525D1 (de) 2004-11-11
DK1379262T3 (da) 2005-02-14
CN1245167C (zh) 2006-03-15
PL204867B1 (pl) 2010-02-26
US20040109907A1 (en) 2004-06-10
DE60201525T2 (de) 2006-03-02
WO2002083158A1 (fr) 2002-10-24
FR2823116A1 (fr) 2002-10-11
KR20030087068A (ko) 2003-11-12
ATE278411T1 (de) 2004-10-15
KR100876233B1 (ko) 2008-12-26

Similar Documents

Publication Publication Date Title
HK1066164A1 (en) Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
CA2031384C (en) Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations
JPH05260907A (ja) 低カフェイン含量茶ポリフェノールの製造法
EP1755629A1 (de) Ginkgo biloba extrakt und verfahren zu seiner herstellung
CN103463953A (zh) 一种甲醛去除剂
HK1065939A1 (en) Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
CN101822750A (zh) 金花茶茶多酚缓释微球颗粒及其生产方法
CN101692932B (zh) 含有茶多糖的卷烟及其制备方法
CN111944165B (zh) 一种多酚类酪氨酸酶抑制剂及其提取方法和应用
CN108653202A (zh) 一种清眸组合物、包含其的眼液及其制备方法
CN109549880A (zh) 一种啤酒花美白提取液的制备方法
KR101070708B1 (ko) 보령산 머드 추출물의 추출방법 및 그 추출물을 함유하는 미백기능성 화장료 조성물
JPH04182434A (ja) いちょう葉抽出物を取得する方法
JPH03218320A (ja) 抗菌周病及び口臭の予防剤
JPH03227985A (ja) イチョウ葉からフラボノイドを高含有する抽出物の簡易な製造法
CN1099294C (zh) 一种银杏注射液的制备方法
JPH02193907A (ja) イチョウエキスの製法
CN106581308A (zh) 一种用于心脑健的茶叶提取物的制备方法
CN116178583B (zh) 党参多糖酸剪切片段cpp-1-1及其制备方法和应用
KR940018077A (ko) 화장료
CN109620788B (zh) 一种茶多酚提取工艺及其在美容美白液中的应用
CN101780122A (zh) 一种水溶性银杏提取物的制备方法
CN106726891A (zh) 金花茶沐浴露的生产方法
CN106726890A (zh) 金花茶洗发液的生产方法
KR890000651B1 (ko) 은행잎으로부터 고농도의 푸라보노이드의 추출방법

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130409